NSE
Lasa Supergenerics LimitedLASA
Lasa Supergenerics Limited is an Indian pharmaceutical company engaged in the manufacturing and distribution of generic drugs.
| Key products | Generic drugs |
|---|---|
| Geography | India |
| Competitors | Dr Reddy's Laboratories, Cipla |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Annual General Meeting
ex 2024-09-20
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹5.2 Cr | 159 | — | — | — | — |
| 2 | MOBIKWIK | +₹0.1 Cr | 83 | — | — | — | — |
| 3 | QUADFUTURE | +₹0 Cr | 134 | — | — | — | — |
| 4 | LASAThis | — | — | — | — | — | — |
| 5 | MTNL | +₹0 Cr | 2 | — | — | — | — |
| 6 | GATECH | +₹0 Cr | 8 | — | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2025-09-08BulkSELL · ₹0.2 CrAMIT KUMAR JAIN HUF
- 2025-09-08BulkBUY · ₹0.4 CrAMIT KUMAR JAIN HUF
- 2025-09-08NetDay net +₹0.2 Cr
- 2025-05-22BulkSELL · ₹0.5 CrBNP ENTERPRISES
- 2025-05-22NetDay net −₹0.5 Cr
- 2024-09-20ActionAnnual General MeetingMeeting
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
No scored filings for LASA yet.
3 deals · 2025-05-22 → 2025-09-08
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-09-08 | AMIT KUMAR JAIN HUF | HNI / other | SELL | ₹0.2 Cr |
| 2025-09-08 | AMIT KUMAR JAIN HUF | HNI / other | BUY | ₹0.4 Cr |
| 2025-05-22 | BNP ENTERPRISES | HNI / other | SELL | ₹0.5 Cr |
3 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on LASA
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.